aberrations and healthy adequate to tolerate FCR therapy, should be excellent candidates with the latter, Along with the benefit currently being this procedure could be concluded in six months although ibrutinib need to be taken indefinitely. Dilisensikan di tiga yurisdiksi—Gibraltar, Μa